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Abstract
Purpose To study the protective effects and underlying
molecular mechanisms of SAMC on carbon tetrachloride
(CCl4)-induced acute hepatotoxicity in the mouse model.
Methods Mice were intraperitoneally injected with CCl4
(50 ll/kg; single dose) to induce acute hepatotoxicity with
or without a 2-h pre-treatment of SAMC intraperitoneal
injection (200 mg/kg; single dose). After 8 h, the blood
serum and liver samples of mice were collected and sub-
jected to measurements of histological and molecular
parameters of hepatotoxicity.
Results SAMC reduced CCl4-triggered cellular necrosis
and inflammation in the liver under histological analysis.
Since co-treatment of SAMC and CCl4 enhanced the
expressions of antioxidant enzymes, reduced the nitric
oxide (NO)-dependent oxidative stress, and inhibited lipid
peroxidation induced by CCl4. SAMC played an essential
antioxidative role during CCl4-induced hepatotoxicity.
Administration of SAMC also ameliorated hepatic
inflammation induced by CCl4 via inhibiting the activity of
NF-jB subunits p50 and p65, thus reducing the expressions
of pro-inflammatory cytokines, mediators, and chemo-
kines, as well as promoting pro-regenerative factors at both
transcriptional and translational levels.
Conclusions Our results indicate that SAMC mitigates
cellular damage, oxidative stress, and inflammation in
CCl4-induced acute hepatotoxicity mouse model through
regulation of NF-jB. Garlic or garlic derivatives may
therefore be a potential food supplement in the prevention
of liver damage.
Keywords Liver injury  S-allylmercaptocysteine 
Carbon tetrachloride  Oxidative stress 
Necroinflammation  Nuclear factor jB
Introduction
As a potent hepatotoxin, carbon tetrachloride (CCl4) con-
tinues to serve as an important substance in medicinal
research, particularly in the investigation of hepatotoxin-
induced liver diseases [1]. CCl4 activates the 2E1 isoform
of cytochrome P450 (CYP2E1) and then forms highly
reactive species CCl3* and CCl3OO* which initiates lipid
peroxidation. Those reactive oxygen species (ROS) cause
oxidative stress in the liver and attack several cellular
targets, including endoplasmic reticulum, mitochondrial,
and plasma membranes, which contribute to further cell
damage. At the molecular level, CCl4 induces the expres-
sion of pro-inflammatory cytokines of tumor necrosis
factor alpha (TNF-a) and interleukin-1 beta (IL-1b), which
mediate the processes of apoptosis, inflammation, and
fibrosis. On the other hand, treatment of CCl4 also activates
transforming growth factors (TGF-a and TGF-b) which
leads to the development of liver fibrosis [2].
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Daily consumption of garlic and garlic-related products
in several countries, including the United States, decreased
the risk of colon and stomach cancer [3]. Previous research
also revealed that S-allylmercaptocysteine (SAMC), the
naturally occurring water-soluble derivative of garlic,
possesses anti-tumor properties in several cancers. In colon
cancer cells, SAMC is shown to inhibit cell growth, arrest
cell cycle, and induces apoptosis via depolymerizing
microtubule, activate JNK1 and caspase-3 [4], as well as
inactivating transcription factor NF-jB [5]. In addition, in
human gastric cancer cells, the anti-proliferative and pro-
apoptosis effects of SAMC are associated with induction of
caspase-3, caspase-9, p53, and Bax, rather than Bcl-2 and
p21 [6]. In vivo study of androgen-independent prostate
cancer model points out that SAMC suppresses metastasis
via up-regulating cell adhesion molecules E-cadherin [7].
In rat cells and animal model, SAMC is also shown to play
antioxidative effects in vitro and attenuates oxidative and
nitrosative stresses in vivo [8]. In an acetaminophen-
induced liver injury model, SAMC exerts its protective
effects against hepatotoxicity by the inhibition of CYP2E1
enzymatic activity, leading to the suppression of acetami-
nophen arylation of hepatic proteins [9].
Although some efforts have been made to investigate the
protection of SAMC in CCl4-induced liver damage [10],
there is a lack of information on the molecular mechanisms
of SAMC on such protection, especially on the attenuation
of hepatic oxidative stress and inflammation. In the present
study, we investigated the detailed molecular mechanisms
of the protective role of SAMC in CCl4-induced acute
hepatotoxicity, which may shed some light on the pre-
vention of liver damage by taking SAMC as a supplement
in the daily diet.
Materials and methods
Reagents
SAMC pure powder was a generous gift from Dr. Patrick M.
T. Ling. It was dissolved in solvent buffer (10% L-dextrose
and 1% gum Arabic (w/v) in phosphate-buffered saline, pH
4.5). Carbon tetrachloride was purchased from Tianjin
Baishi Chemical (Tianjin, China). Murine anti-nitrotyrosine
monoclonal antibody was purchased from Zymed (San
Francisco, CA). Rabbit anti-CYP2E1 and anti-IjBa poly-
clonal antibodies were purchased from Millipore (Billerica,
MA) and Cell Signaling (Danvers, MA), respectively.
Animals and treatment
Eight- to ten-week healthy male and female C57BL/b6N
mice were purchased from the Laboratory Animal Unit
(LAU), The University of Hong Kong. Mice were kept
under standard conditions 1 week before CCl4 treatment
with free access to animal chow and tap water. The animals
were divided into four groups (n = 8–10 in each group):
(1) control with vehicle administration (PBS or olive oil);
(2) CCl4 single-dose treatment (50 ll/kg in olive oil;
intraperitoneal injection); (3) SAMC single-dose treatment
(200 mg/kg in PBS; intraperitoneal injection); and (4) CCl4
and SAMC co-treatment. The optimum dosage of SAMC
used was previously shown to be effective in protecting
from oxidative stress in mice [11]. SAMC pre-treatment
was performed 2 h before the CCl4 injection. After 8 h of
CCl4 treatment, the mice were killed by an overdose of
anesthesia according to the protocols approved by the
Committee of Animal Use for Research and Teaching at
The University of Hong Kong. The Laboratory Animal
Unit of the University of Hong Kong is fully accredited
by the Association for Assessment and Accreditation of
Laboratory Animal Care International (AAALAC interna-
tional). Blood and liver samples were collected for further
analysis.
Tissue and blood samples processing
and histopathological analysis
Serum were collected by centrifugation of whole blood
sample at 1,0009g for 10 min at 4 C and stored at
-80 C. Liver tissue samples were fixed in 10% phos-
phate-buffered formalin, processed for histology, and
embedded in paraffin. Five-micrometer tissue sections
were stained with hematoxylin and eosin for histological
analysis under LEICA Qwin Image Analyser (Leica
Microsystems Ltd., Milton Keynes, UK).
Serum alanine aminotransferase assay
The level of hepatic injury can be detected by the increased
level of alanine aminotransferase (ALT) in the serum. The
ALT assay was performed by procedures described previ-
ously [12].
RNA extraction and quantitative reverse-transcription
polymerase chain reaction (real-time PCR)
Total RNA was extracted from the liver samples using
illustraTM RNAspin mini kit (GE healthcare, UK). The
preparation of the first-strand cDNA was conducted fol-
lowing the instruction of the SuperScriptTM First-Strand
Synthesis System (Invitrogen, Calsbad, CA).
The mRNA expression levels of tumor necrosis factor
alpha (TNF-a), interleukin-1 beta (IL-1b), inducible nitric
oxide synthase (iNOS), cyclooxygenase-2 (COX-2), glu-
tathione peroxidase (GPx), catalase (CAT), Cu/Zn SOD,
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monocyte chemoattractant protein-1 (MCP-1), macrophage
inflammatory protein-2 (MIP-2), KC (murine IL-8 ortho-
log), interleukin-6 (IL-6), and transforming growth factor
beta1 (TGF-b1) were measured by real-time PCR. The
primers used in those real-time PCR reactions are listed in
Table 1. The annealing temperature of each reaction has
been adjusted to 58 C. Parallel amplification of glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) was used
as the internal control. Relative quantification was per-
formed using the 2-DDCt method. The relative expression
of the specific gene to the internal control was obtained and
then expressed as percentage of the control expression in
the Figures.
Determination of malondialdehyde level
The malondialdehyde (MDA) levels of liver samples were
determined using a Bioxytech LPO-586TM kit (Oxis
Research, Portland, OR). The reaction product was mea-
sured spectrophotometrically at 586 nm. Standard curves
were constructed using 1,1,3,3-tetraethoxypropane as a
standard. The MDA levels were normalized with corre-
sponding protein amounts determined by Bio-Rad Protein
Assay Kit (Bio-Rad, Hercules, CA) and represented as
percentage against control level.
Western blotting
Protocols for cytosolic and nuclear protein extraction
were previously described [12]. Protein was diluted and
mixed with 29 sample buffer (0.1 M Tris–HCl, pH 6.8,
20% glycerol, 4% sodium dodecyl sulfate, 0.2% bromo-
phenol blue, and 5.25% b-mercaptoethanol). The mixture
was denatured at 95 C for 5 min and followed by
electrophoresis in a 10% polyacrylamide gel. The protein
was then transferred to an Immun-BlotTM PVDF Mem-
brane (Bio-Rad) in a TE series transfer electrophoresis
unit (Hoefer Inc., Holliston, MA). The membrane was
then incubated in blocking buffer (5% nonfat milk
powder in TBST) for 1 h followed by incubation with
primary antibodies (1:1,000 dilution for nitrotyrosine and
IjBa; 1:2,000 dilution for CYP2E1) in TBST (100 mM
Tris–HCl, pH 7.5, 0.9% NaCl, and 0.1% Tween 20)
overnight at 4 C with gentle agitation. On the following
day, the membrane was washed with TBST and incu-
bated with appropriate secondary antibodies (1:2,000
dilution in TBST) for 2 h at room temperature. Beta actin
(Monoclonal; 1:5,000; Sigma, St. Louis, MO) was used
as the internal control. After washing off the unbound
antibody with TBST, the expression of the antibody-
linked protein was determined by an ECLTM Western
Blotting Detection Reagents (GE Healthcare). The optical
density of the bands was measured and quantified by
ImageJ software. The ratio of the optical density of the
protein product to the internal control was obtained and
was expressed as percentage of the control expression in
the Figures.
Enzyme-linked immunosorbent assay measurement
Enzyme-linked immunosorbent assay (ELISA) measure-
ments of IL-1b, KC, IL-6, and TGF-b1 protein expression
levels were performed using ELISA development kits from
PeproTech (PeproTech Inc., Rocky Hill, NJ). ELISA of
COX-2 was conducted using kit purchased from EIAab
(Wuhan EIAab Science, Wuhan, China).
Determination of DNA-binding activity of nuclear
factor-jB
The assay on the DNA-binding activity of nuclear factor-
jB (NF-jB) was performed by electrophoretic mobility
shift assay (EMSA) using the Gel Shift Assay Systems
Table 1 Primer sequences for quantitative PCR
Target
gene
Direction Sequence
TNF-a Forward 50-ATGAGCACAGAAAGCATGATC-30
Reverse 50-TACAGGCTTGTCACTCGAATT-30
IL-1b Forward 50-CAGGCAGGCAGTATCACTCA-30
Reverse 50-AGGCCACAGGTATTTTGTCG-30
iNOS Forward 50-GTGGTGACAAGCACATTTGG-30
Reverse 50-GGCTGGACTTTTCACTCTGC-30
COX-2 Forward 50-GGAGAGACTATCAAGATAGTGATC30
Reverse 50-ATGGTCAGTAGACTTTTACAGCTC-30
GPx Forward 50-TCCACCGTGTATGCCTTCTCC-30
Reverse 50-CCTGCTGTATCTGCGCACTGGA-30
CAT Forward 50-GAGGCAGTGTACTGCAAGTTCC-30
Reverse 50-GGGACAGTTCACAGGTATCTGC-30
Cu/Zn SOD Forward 50-CGAGCAGAAGGCAAGC-30
Reverse 50-GCCCAGGTCTCCAACA-30
MCP-1 Forward 50-ACCAGCCAACTCTCACTGAAGC-30
Reverse 50-CAGAATTGCTTGAGGTGGTTGTG-30
MIP-2 Forward 50-AGTGAACTGCGCTCTCAATG-30
Reverse 50-CTTTGGTTCTTCCGTTGAGG-30
KC Forward 50-CTGTCAGTGCCTGCAGACCA-30
Reverse 50-CCAAGGGAGCTTCAGGGTCA-30
IL-6 Forward 50-CCGGAGAGGAGACTTCACAG-30
Reverse 50-GGAAATTGGGGTAGGAAGGA-30
TGF-b1 Forward 50-CTTCAGCTCCACAGAGAAGAACTGC-30
Reverse 50-CACGATCATGTTGGACAACTGCTCC-30
GAPDH Forward 50-CCTTCATTGACCTCAACTACATGGT-30
Reverse 50-TCATTGTCATACCAGGAAATGAGCT-30
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from Promega (Promega, Madison, WI). The assay was
carried out following the protocol described previously
[13]. Briefly, the phosphorylated and purified consensus
NF-jB oligonucleotides (Promega) were mixed with
24 lg of nuclear protein extract and 109 gel shift binding
buffer (200 mm Tris–HCl, pH 7.8, 1 m NaCl, 50 mm
MgCl2, 10 mm EDTA, and 50 mm dithiothreitol). The
mixture was incubated at room temperature for 20 min
prior to electrophoresis on a 4% non-denaturing poly-
acrylamide gel. Signals on exposed X-ray films were
quantified using laser scanning densitometry. Specificity
of NF-jB binding was confirmed by competition assays
and the ability of a specific antibody to supershift protein–
DNA complexes. In the competition assay, the addition of
100-fold excess of unlabeled competitor consensus oligo-
nucleotide prevented binding. Supershift experiments
confirmed the presence of the p50 and p65 subunits in the
binding complexes.
Statistical analysis
Data from each group were expressed as means ± SEM.
Statistical comparison between groups was made using the
Kruskal–Wallis test followed by Dunns post hoc test to
compare all groups. A p \ 0.05 was considered to be sta-
tistically significant (Prism 5.0, Graphpad software, Inc.,
San Diego, CA, USA).
Results
CCl4 treatment induced hepatocyte necrosis and inflam-
mation surrounding the centrilobular veins of the liver
which were obviously attenuated by the pre-treatment of
SAMC (Fig. 1a–d). It should be noted that SAMC injection
alone did not show any histological change in the liver
(Fig. 1c). Serum ALT level of CCl4-treated mice was
approximately 3.5-fold higher than that of the control
group. Pre-treatment of SAMC also significantly reduced
the expression of serum ALT induced by CCl4 to the
control-like level. SAMC treatment alone did not change
the baseline level of serum ALT (Fig. 1e; p \ 0.05). Pre-
vious studies have shown that the isoform 2E1 of cyto-
chrome P450 (CYP2E1) is transiently down-regulated in
the early stage of CCl4 administration as a self-defense
mechanism [14]. In the present study, protein expression of
CYP2E1 was also reduced after CCl4 treatment to
approximately 50% of that in the control group. Treatment
of SAMC alone also led to a significant decrease in
CYP2E1 expression which was around 70% of the control
level. Levels were further reduced in SAMC and CCl4
co-treatment mice when compared with the control group
(Fig. 2a; p \ 0.05).
The mRNA levels of antioxidant enzymes GPx, CAT,
and Cu/Zn SOD were significantly reduced in CCl4 treat-
ment group when compared with the control group. The
mice pre-treated with SAMC followed by CCl4 injection
exhibited similar expression levels of these antioxidant
enzymes as the control group (Fig. 2b–d).
To investigate the effect of SAMC on hepatic lipid
peroxidation, levels of hepatic malondialdehyde (MDA)
were measured after CCl4 with or without SAMC pre-
treatment. When compared with the control group, mice
treated with CCl4 alone showed approximately 3.5-fold
increases in the MDA level. However, pre-treatment with
SAMC significantly reduced the MDA level (Fig. 3a).
Although SAMC treatment alone also slightly increased
the MDA level, the ameliorative effect of SAMC on
hepatic lipid peroxidation is obvious.
As an indicator of cellular oxidative stress and inflam-
mation, the formation of nitrotyrosine was highly elevated
(around 1.7-fold than control level) after CCl4 treatment.
However, when compared with the CCl4 group, mice pre-
treated with SAMC followed by CCl4 showed a significant
reduction in nitrotyrosine formation, which was compara-
ble with the control group (Fig. 3b).
After CCl4 treatment, the mRNA expressions of pro-
inflammatory factors TNF-a, iNOS, IL-1b, and COX-2
were increased by approximately 3.4, 1.6, 1.7, and 4.1-fold,
respectively, when compared with the control group. In the
pre-treatment with SAMC followed by CCl4 group, the
mRNA expression levels of TNF-a, iNOS, and IL-1b were
markedly decreased to the basal levels (Fig. 4a–c). Pre-
treatment with SAMC followed by CCl4 also markedly
reduced the COX-2 mRNA expression when compared
with the CCl4 group, although to a level not as low as the
control group (Fig. 4e). Protein expression levels of IL-1b
and COX-2 confirmed the trends observed in mRNA
results (Fig. 4d, f).
Since the expressions of chemokines in the liver were
up-regulated by cytokines, oxidative products, and growth
factors during inflammation, the change in expression level
and distribution becomes an indicative parameter of
hepatic inflammation and oxidation [15]. After CCl4
challenge, mRNA expressions of monocyte chemoattrac-
tant protein-1 (MCP-1, CCL2), macrophage inflammatory
protein-2 (MIP-2, CXCL3), and murine KC (IL-8 ortholog,
CXCL1) increased by 8, 4.5, and 1.7-fold, respectively,
when compared with the control group, but significantly
reduced in the SAMC and CCl4 treatment group (Fig. 5a–
c). ELISA assay of KC protein expression showed similar
patterns corresponding to its mRNA expression, further
confirming the effect of SAMC on chemokine expressions
(Fig. 5d).
To investigate the effect of SAMC on hepatic regener-
ation, we measured the expressions of IL-6 and TGF-b1,
326 Eur J Nutr (2012) 51:323–333
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which are key genes involved in the processes of regen-
eration, anti-inflammation, and fibrosis. CCl4 challenge
significantly up-regulated the expression of these two
genes, and the group treated with SAMC and CCl4
potentiated such elevated expression (Fig. 6a, c). Protein
expression of IL-6 confirmed the trend of its mRNA
expression (Fig. 6b).
Acute CCl4 treatment markedly up-regulated the activity
level of NF-jB to approximately 2.5-fold of the control.
Pre-treatment with SAMC followed by CCl4 showed a
significant reduction in the activity of NF-jB when com-
pared with the control group. Moreover, cytosolic content
of IjBa was significantly decreased by CCl4 treatment but
restored by the pre-treatment of SAMC (Fig. 7a). Super-
shift assay of p50 and p65 antibodies showed a lighter
intensity and a slight upward retarded shift of the NF-jB
band confirming the specificity of the reactions in the gel
shift assay (Fig. 7b).
Discussion
CCl4 was proven to be a useful experimental model for
hepatotoxicity studies, although banned for industrial and
home use as cleaner and solvent [16]. A huge number of
natural products, mainly originating from traditional Asian
medicine, have been tested recently for the protective
effects against CCl4-induced toxicity such as vitamin E
[17], green tea extracts [18], ginsan [19], coffee [20], and
even mushroom [21]. Because of the similarities in the
mechanism of actions, these protective agents also have the
potential to be used in the treatment of AFLD (alcoholic
fatty liver disease), NAFLD (non-alcoholic fatty liver
disease), and cirrhosis [22, 23]. Sumioka et al. showed that
in overdose acetaminophen-induced liver injury model,
SAMC protected liver from drug-induced damage by
inhibiting CYP2E1 and inducing a biomarker of acetami-
nophen arylation of liver protein [9]. In the present study,
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we demonstrated that administration of SAMC protected
CCl4-induced acute liver injury through different mecha-
nisms, including the inhibition of CYP2E1, down-regula-
tion of inflammatory mediators and nuclear transcription
factor, restoration of intracellular antioxidant enzymes, and
promotion of liver regeneration, which added to the novel
mechanistic aspects of the known beneficial properties of
SAMC.
As an indicative enzyme, ALT is normally contained
within liver cells. After cellular damage, the enzyme is
released into the bloodstream and raising the blood ALT
enzyme level, suggesting the presence of liver damage
[24]. In the present study, CCl4 treatment dramatically
increased the serum ALT level, induced hepatic centri-
lobular necrosis, and increased the number of inflammatory
cells surrounding the centrilobular veins. We found that
pre-treatment with SAMC significantly decreased the
serum ALT biomarker as well as ameliorated hepatocel-
lular injury against CCl4 without affecting the healthy cells
(Fig. 1).
Through the actions of the cytochrome P450 oxygenase
system within the endoplasmic reticulum, mainly the iso-
zyme of CYP2E1, the CCl3* radical is formed by the
metabolism of CCl4. In the presence of oxygen/hydrogen,
CCl3* may convert to CCl3OO*/chloroform to attack many
targets including DNA, amino acid, and proteins. CCl3OO*
can also abstract a hydrogen to form polyunsaturated fatty
acid (PUFA), initiating lipid peroxidation [2]. In a previous
study, it was shown that the expression of CYP2E1 was
down-regulated after CCl4 intoxication as an adaptive
mechanism to limit hepatotoxicity. In addition, restoration
of CYP2E1 expression or stabilization of this enzyme
made CCl4-induced injury more severe [14]. This finding
was further confirmed by a protective assay of ginsan,
which is an antioxidant compound from plant, in CCl4-
induced hepatic injury model [19]. In this study, SAMC
potentiated the down-regulation of CYP2E1 expression
induced by CCl4. Moreover, SAMC further demonstrated
its protective properties by attenuating CCl4-induced
oxidative stress through the reduction in nitrotyrosine for-
mation and MDA, the end-products of nitric oxide (NO)
and lipid peroxidation, respectively (Fig. 3). In the present
study, we further investigated the expression of several
hepatic antioxidant enzymes after CCl4 challenge. CCl4
treatment alone significantly decreased the mRNA
expressions of GPx, CAT, and Cu/Zn SOD, whereas pre-
treatment with SAMC followed by CCl4 had the expres-
sions of those enzymes similar to baseline levels (Fig. 2).
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Since Cu/Zn SOD is the main antioxidant which dismutate
O2 into H2O2 and CAT/GPx are enzymes which degrade
H2O2 [25], these findings are consistent with results seen in
the nitrotyrosine and MDA assays, further lending more
support to the antioxidative effect of SAMC in mice.
Taking all findings together, SAMC protected CCl4-
induced oxidative stress at different mechanisms.
To further study the mechanism of the protective roles
of SAMC, we measured the expressions of inflammatory
mediators after CCl4 treatment. It has been reported that
hepatic inflammatory responses are initiated as early as
30 min after CCl4 exposure [2]. Pro-inflammatory
cytokines, TNF-a, and IL-1b are released from Kupffer
cells, the resident macrophages in the liver [26]. When
cellular RNA and protein synthesis are repressed by CCl4
exposure, hepatocytes becomes sensitized to TNF-a, which
induces the activity of transcription factors NF-jB, AP-1,
and STAT-3 [27]. Normally, TNF-a suppresses hepato-
cellular apoptosis or even to affect recovery through its
conjugate receptor TNFR1 and another family member of
interleukin, IL-6 [28]. However, when CCl4 inhibits cel-
lular protein synthesis, this cytokine becomes a pro-apop-
totic factor which potentiates the apoptotic signaling
cascade from ROS-damaged mitochondria [29]. Similar to
TNF-a, when associated with oxidative stress induced by
CCl4, IL-1b also triggers cellular necrosis and apoptosis
pathways by changing the balance of ligand and receptor
[30, 31]. Moreover, elevated expression of TNF-a and
IL-1b also stimulates the production of NO, a highly
reactive oxidant molecule produced by both parenchymal
and non-parenchymal liver cells via iNOS [32]. In the
current study, SAMC greatly reduced the expression levels
of pro-inflammatory mediators induced by CCl4 exposure
at both transcriptional and translational level, confirming
its protective role against CCl4. Since pre-treatment with
SAMC also decreased the protein level of NO metabolic
product nitrotyrosine, it could be suggested that the inhi-
bition of pro-inflammatory cytokines and the restoration of
antioxidant enzymes during SAMC pre-treatment followed
by CCl4 intoxication not only prevented cellular necrosis
and apoptosis, but also repressed the positive-feedback
loop between inflammation, lipid peroxidation, and
oxidative stress.
Up-regulation of chemokines in the liver is a part of the
inflammation response to haloalkane intoxication, e.g.,
CCl4, via controlling migration and recruitment of both the
inflammatory Kupffer cells and the non-inflammatory
stellate cells [15]. Since MCP-1 [33], MIP-2 [34], and KC
(mouse IL-8 otholog) [35] are induced by cytokines (e.g.,
TNF-a) in the inflammatory microenvironment, we tested
the effects of SAMC pre-treatment on their expressions
after CCl4 exposure. Both mRNA and protein levels of
these chemokines were significantly down-regulated by the
pre-treatment of SAMC followed by CCl4, which demon-
strated that the anti-inflammation property of SAMC was
involved in the regulation of both the inflammatory factors
and chemokines.
As an acute phase response factor, IL-6 antagonizes
TNFa-induced inflammation and stabilizes cell membranes
after CCl4 treatment, protecting cells from oxidative stress
[27]. IL-6 also binds to both membrane-bound IL-6
receptor and soluble IL-6 receptor to trigger NF-jB- and
STAT3-dependent hepatic regeneration [36, 37]. TGF-b1 is
mainly a pro-fibrotic factor in chronic liver disease, e.g.,
fatty liver disease. However, a recent study also found its
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role in promoting hepatic remodeling during the process of
liver regeneration through increasing the expression of a
cell adhesion molecule known as gicerin [38]. In the
present study, SAMC potentiated the induced IL-6 and
TGF-b1 expressions after CCl4 treatment, suggesting the
pro-regenerative and the anti-inflammatory properties in
SAMC during the early phase of CCl4 intoxication. This
finding is consistent with other reported studies using
different antioxidants [19].
When an intermediate amount of ROS is generated by
CCl4 exposure, transcription factors (e.g., NF-jB and
AP-1) are activated and translocated into the nucleus.
NF-jB and AP-1 then promote the transcription of more
inflammatory cytokines and chemokines which form a
positive-feedback loop to potentiate the inflammatory
response [39, 40]. Moreover, H2O2 and NO formed during
CCl4 intoxication also directly modulate NF-jB activation
via an IKK-dependent degradation of IjBa pathway,
making this transcription factor a central regulatory mol-
ecule in regulating CCl4-induced oxidation and inflamma-
tion [41, 42]. In the current study, administration of SAMC
prior to CCl4 challenge significantly reduced the NF-jB
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presented are expressed as
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activity through the degradation of cytosolic IjBa. Thus,
SAMC may ameliorate both oxidative stress and inflam-
matory signaling through regulation in the activity of the
transcription factor NF-jB.
In conclusion, this study showed that the administration
of garlic-derived SAMC was effective in ameliorating
CCl4-induced hepatotoxicity through the regulation of
oxidative stress, inflammatory signaling, and liver regen-
eration in association with the reduction in the activity of
the transcription factor NF-jB. Since AFLD, NAFLD, and
other xenobiotics share a similar mechanism in liver
damage with the CCl4 intoxication model, the hepatopro-
tective properties of SAMC are of significant clinical
application in the prevention and treatment of chronic liver
diseases. Compared with other antioxidant agents reported
recently, garlic is easier to purchase and in an abundant
supply, so it could be used as a daily food supplement
which may prevent the onset of liver injury.
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